标题
Other markers of medullary thyroid cancer, not only calcitonin
作者
关键词
-
出版物
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 188, Issue 1, Pages -
出版商
Oxford University Press (OUP)
发表日期
2023-01-04
DOI
10.1093/ejendo/lvac009
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer
- (2022) S. Filetti et al. ANNALS OF ONCOLOGY
- Diagnostic Utility of Procalcitonin for Sporadic Medullary Thyroid Carcinoma in Patients with Nodular Disease and Mild or Moderate Hypercalcitoninemia
- (2022) Pedro Weslley Rosario et al. HORMONE AND METABOLIC RESEARCH
- Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature
- (2022) Andrea Corsello et al. THYROID
- Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations
- (2021) Juanjuan Dong et al. Cancer Management and Research
- Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma
- (2021) Luca Giovanella et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma
- (2021) Antonio Matrone et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities
- (2021) Loredana Lorusso et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
- (2021) Simona Censi et al. Frontiers in Endocrinology
- MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives
- (2021) Francesca Galuppini et al. Cells
- Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma
- (2021) Jürgen Kratzsch et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
- (2021) Simona Censi et al. Frontiers in Endocrinology
- Early diagnosis of medullary thyroid cancer: Are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?
- (2020) Martin B. Niederle et al. THYROID
- Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
- (2020) L. Fugazzola et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- 1913O Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
- (2020) M. Hu et al. ANNALS OF ONCOLOGY
- ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus.
- (2020) Elisa Giannetta et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- An investigation on the expression of miRNAs including miR‐144 and miR‐34a in plasma samples of RET ‐positive and RET ‐negative medullar thyroid carcinoma patients
- (2019) Noushin Shabani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
- (2019) Giuseppe Lippi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules
- (2019) Aisen Zhang et al. DISEASE MARKERS
- Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia
- (2018) Luca Giovanella et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
- (2018) Paola Romeo et al. ENDOCRINE-RELATED CANCER
- Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules
- (2018) Luca Giovanella et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Calcium-stimulated calcitonin - The “new standard” in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an “old test”
- (2018) Martin B. Niederle et al. Biochemia Medica
- Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame
- (2017) Vincenzo Marotta et al. ENDOCRINE-RELATED CANCER
- Comparison of the Elecsys calcitonin assay with the Immulite 1000 assay. Describing one case with heterophilic antibody interference
- (2016) Phuong-Nhi Bories et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Calcitonin measurement and immunoassay interference: a case report and literature review
- (2016) Simona Censi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay
- (2016) Thalita G. Alves et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
- (2016) Susi Barollo et al. PLoS One
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature
- (2015) Pierpaolo Trimboli et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Procalcitonin for detecting medullary thyroid carcinoma: a systematic review
- (2015) P. Trimboli et al. ENDOCRINE-RELATED CANCER
- Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer
- (2015) Rossella Elisei et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Medullary Thyroid Cancer With Undetectable Serum Calcitonin
- (2015) Erika F. Brutsaert et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Utility of Serum Procalcitonin for Screening and Risk Stratification of Medullary Thyroid Cancer
- (2014) Andreas Machens et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers
- (2014) P. Ferolla et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy
- (2013) R. Kurzrock et al. ANNALS OF ONCOLOGY
- Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules
- (2013) Luca Giovanella et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Medullary Thyroid Cancer Secreting Carbohydrate Antigen 19-9 (Ca 19-9): A Fatal Case Report
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma
- (2013) Satoshi Watanabe et al. LUNG CANCER
- Influence of Chronic Autoimmune Thyroiditis and Papillary Thyroid Cancer on Serum Calcitonin Levels
- (2013) Pedro Weslley Rosario et al. THYROID
- Serum Procalcitonin and Calcitonin Normal Values Before and After Calcium Gluconate Infusion
- (2012) L. Giovanella EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
- (2012) Caterina Mian et al. THYROID
- Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
- (2012) Karin Frank-Raue et al. THYROID
- Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
- (2011) Nils Bolstad et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Metastatic Medullary Thyroid Cancer Presenting with Elevated Levels of CA 19-9 and CA 125
- (2011) Sofiya Milman et al. THYROID
- Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer
- (2010) Andreas Machens et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA control of signal transduction
- (2010) Masafumi Inui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Potency and Tolerance of Calcitonin Stimulation with High-Dose CalciumVersusPentagastrin in Normal Adults
- (2009) Patricia Doyle et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Sporadic hypercalcitoninemia: clinical and therapeutic consequences
- (2008) C Scheuba et al. ENDOCRINE-RELATED CANCER
- Procalcitonin: A Marker for the Diagnosis and Follow-Up of Patients with Medullary Thyroid Carcinoma
- (2008) Alicia Algeciras-Schimnich et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Normal Perioperative Serum Calcitonin Levels in Patients with Advanced Medullary Thyroid Carcinoma: Case Report and Review of the Literature
- (2008) José Miguel Dora et al. THYROID
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now